Follow
Nissim Hay
Nissim Hay
Unknown affiliation
Verified email at uic.edu
Title
Cited by
Cited by
Year
Upstream and downstream of mTOR
N Hay, N Sonenberg
Genes & development 18 (16), 1926-1945, 2004
54022004
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.
SG Kennedy, AJ Wagner, SD Conzen, J Jordan, A Bellacosa, PN Tsichlis, ...
Genes & development 11 (6), 701-713, 1997
13611997
The pentose phosphate pathway and cancer
KC Patra, N Hay
Trends in biochemical sciences 39 (8), 347-354, 2014
13212014
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene
WS Chen, PZ Xu, K Gottlob, ML Chen, K Sokol, T Shiyanova, I Roninson, ...
Genes & development 15 (17), 2203-2208, 2001
12162001
The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB
ES Kandel, N Hay
Experimental cell research 253 (1), 210-229, 1999
12041999
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
SM Jeon, NS Chandel, N Hay
Nature 485 (7400), 661-665, 2012
11472012
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase
K Gottlob, N Majewski, S Kennedy, E Kandel, RB Robey, N Hay
Genes & development 15 (11), 1406-1418, 2001
11372001
4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway
AC Gingras, SG Kennedy, MA O’Leary, N Sonenberg, N Hay
Genes & development 12 (4), 502-513, 1998
11371998
The two TORCs and AKT
PT Bhaskar, N Hay
Developmental cell 12 (4), 487-502, 2007
10152007
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2
X Peng, PZ Xu, ML Chen, A Hahn-Windgassen, J Skeen, J Jacobs, ...
Genes & development 17 (11), 1352-1365, 2003
9852003
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
N Hay
Nature Reviews Cancer 16 (10), 635-649, 2016
9712016
The Akt-mTOR tango and its relevance to cancer
N Hay
Cancer cell 8 (3), 179-183, 2005
9392005
Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis
V Nogueira, Y Park, CC Chen, PZ Xu, ML Chen, I Tonic, T Unterman, ...
Cancer cell 14 (6), 458-470, 2008
8672008
Akt/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cytochrome c from Mitochondria
SG Kennedy, ES Kandel, TK Cross, N Hay
Molecular and cellular biology 19 (8), 5800-5810, 1999
8521999
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer
KC Patra, Q Wang, PT Bhaskar, L Miller, Z Wang, W Wheaton, N Chandel, ...
Cancer cell 24 (2), 213-228, 2013
8082013
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
AJ Wagner, JM Kokontis, N Hay
Genes & development 8 (23), 2817-2830, 1994
7651994
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak
N Majewski, V Nogueira, P Bhaskar, PE Coy, JE Skeen, K Gottlob, ...
Molecular cell 16 (5), 819-830, 2004
7642004
Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity
A Hahn-Windgassen, V Nogueira, CC Chen, JE Skeen, N Sonenberg, ...
Journal of Biological Chemistry 280 (37), 32081-32089, 2005
6962005
Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
RB Robey, N Hay
Seminars in cancer biology 19 (1), 25-31, 2009
6652009
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt
RB Robey, N Hay
Oncogene 25 (34), 4683-4696, 2006
6412006
The system can't perform the operation now. Try again later.
Articles 1–20